Last reviewed · How we verify
NCT02667158
A Survey to Eval the Relation Between Doctor/Pharmacy Shopping and Outcomes Suggestive of Misuse, Abuse and/or Diversion
trial testing Survey to Eval Relation between Shopping and Misuse, Abuse in Opioid-Related Disorders in 1,085 participants. Completed in 19 December 2018.
19 December 2018
Quick facts
| Lead sponsor | Member Companies of the Opioid PMR Consortium |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,085 |
| Start date | 7 November 2014 |
| Primary completion | 19 December 2018 |
| Estimated completion | 19 December 2018 |
Drugs / interventions tested
- Survey to Eval Relation between Shopping and Misuse, Abuse
Conditions studied
- Opioid-Related Disorders — all drugs for Opioid-Related Disorders →
- Opiate Addiction — all drugs for Opiate Addiction →
- Narcotic Abuse — all drugs for Narcotic Abuse →
- Drug Abuse — all drugs for Drug Abuse →
Sponsor
Member Companies of the Opioid PMR Consortium
Who can join
18 and older, any sex, with Opioid-Related Disorders or Opiate Addiction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the reasons patients go to more than one prescriber or more than one pharmacy to obtain prescriptions opioids and assess whether the percentage of patients reporting misuse, abuse and/or diversion increases across defined categories of doctor/pharmacy shopping as defined in Study 4A.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02667158
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Opioid-Related Disorders
Currently open trials in the same condition.
- NCT06810076 — Developing and Evaluating a Machine-Learning Opioid Overdose Prediction & Risk-Stratification Tool in Primary Care · NA · active not recruiting
- NCT06454903 — Developing a Smartphone Application to Support Veteran Opioid Use Disorder Treatment · NA · recruiting
- NCT06387290 — Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits · Phase 3 · recruiting
- NCT06023459 — Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR) · Phase 3 · active not recruiting
- NCT06001749 — Psilocybin in Cancer Pain Study · Phase 2 · recruiting
Other Member Companies of the Opioid PMR Consortium trials
Trials by the same sponsor.
- NCT02662153 — Incidence and Predictors of Opioid Overdose and Death Among Long-Term Users of Opioid Analgesics · completed
- NCT02751762 — A Prospective Investigation of the Risks of Opioid Misuse, Abuse, and Addiction Among Patients Treated With Opioids for · completed
- NCT02741076 — Discontinuation vs Continuation of Long-term Opioid Therapy in Suboptimal and Optimal Responders With Chronic Pain · Phase 4 · terminated
- NCT02660619 — Validation of PRISM-5-Op, Measure Of Addiction To Prescription Opioid Medication · completed
- NCT02667262 — An Observational Study to Develop Algorithms for Identifying Opioid Abuse and Addiction Based on Admin Claims Data · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02667158 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Member Companies of the Opioid PMR Consortium
- Last refreshed: 15 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02667158.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing